SPDR S&P Biotech ETF $XBI Shares Sold by HighTower Advisors LLC

HighTower Advisors LLC cut its holdings in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 5.3% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 72,522 shares of the exchange traded fund’s stock after selling 4,063 shares during the period. HighTower Advisors LLC’s holdings in SPDR S&P Biotech ETF were worth $8,843,000 at the end of the most recent quarter.

Other hedge funds have also recently made changes to their positions in the company. Compass Wealth Management LLC acquired a new position in shares of SPDR S&P Biotech ETF in the 3rd quarter valued at $1,167,000. China Universal Asset Management Co. Ltd. increased its position in shares of SPDR S&P Biotech ETF by 868.3% in the 3rd quarter. China Universal Asset Management Co. Ltd. now owns 4,919 shares of the exchange traded fund’s stock valued at $493,000 after acquiring an additional 4,411 shares during the period. Ashton Thomas Private Wealth LLC acquired a new position in shares of SPDR S&P Biotech ETF in the 3rd quarter valued at $417,000. Apella Capital LLC acquired a new position in shares of SPDR S&P Biotech ETF in the 4th quarter valued at $490,000. Finally, Banque Pictet & Cie SA increased its position in shares of SPDR S&P Biotech ETF by 24.1% in the 4th quarter. Banque Pictet & Cie SA now owns 64,877 shares of the exchange traded fund’s stock valued at $7,910,000 after acquiring an additional 12,595 shares during the period.

SPDR S&P Biotech ETF Price Performance

NYSEARCA XBI opened at $131.66 on Tuesday. The stock’s fifty day moving average price is $130.00 and its 200 day moving average price is $125.32. SPDR S&P Biotech ETF has a 1 year low of $78.00 and a 1 year high of $139.19. The company has a market cap of $8.40 billion, a price-to-earnings ratio of 11.47 and a beta of 0.85.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.